NCT01276405终止不适用
The Efficacy of Adjuvant Chemotherapy With Capecitabine (Xeloda) Monotherapy in Patients With Colon Cancer Stage III (Duke C) Considering the Histopathology of the Tumour (AXEL)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 123
- 主要终点
- Disease-free survival
研究概览
简要总结
This observational study will evaluate Xeloda (capecitabine) monotherapy on the effect of disease-free survival in patients with colon cancer stage III (Duke C) after surgical resection. Data will be collected for 3 years.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, over the age of 18 years
- •Presence of colon adenocarcinoma
- •Surgical resection for colon cancer stage III (Duke C)
- •Prior adjuvant therapy with Xeloda monotherapy
排除标准
- •Contraindications for Xeloda
结局指标
主要结局
Disease-free survival
时间窗: 3 years
次要结局
- Safety (Incidence of adverse events)(3 years)
研究者
相似试验
Unknown
2 期
Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisGastric CancerNCT01167049Peking University Cancer Hospital & Institute60
已完成
3 期
A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerGastric CancerNCT02560974Hoffmann-La Roche1,035
已完成
1 期
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerCancerNCT00003704Alliance for Clinical Trials in Oncology51
已完成
不适用
An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal CancerColorectal CancerNCT01696695Hoffmann-La Roche882
撤回
1 期
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerEndometrial CancerOvarian CancerCervical CancerVaginal CancerNCT00118300Case Comprehensive Cancer Center